Trial Registration: http://www.ClinicalTrials.gov, ID#NCT00633984, http://www.clinicaltrials.gov/ct2/show/NCT00633984
SLEEP QUALITY PREDICTS TREATMENT OUTCOME IN CBT FOR SOCIAL ANXIETY DISORDER
Version of Record online: 26 AUG 2013
© 2013 Wiley Periodicals, Inc.
Depression and Anxiety
Volume 30, Issue 11, pages 1114–1120, November 2013
How to Cite
Zalta, A. K., Dowd, S., Rosenfield, D., Smits, J. A. J., Otto, M. W., Simon, N. M., Meuret, A. E., Marques, L., Hofmann, S. G. and Pollack, M. H. (2013), SLEEP QUALITY PREDICTS TREATMENT OUTCOME IN CBT FOR SOCIAL ANXIETY DISORDER. Depress. Anxiety, 30: 1114–1120. doi: 10.1002/da.22170
Conflict of Interest: Dr. Zalta declares no conflicts of interest. Dr. Dowd reported receiving grant support from NIMH, Neuronetics, Cervel Neurotech, Otsuka, and the Research Foundation for Mental Hygeine and is a consultant for Cervel Neurotech. Dr. Rosenfield reported receiving grant funding from NIMH and consulting for the University of Miami. Dr. Smits reported receiving royalties from various book publishers unrelated to this study. Dr. Otto noted serving as a consultant for MicroTransponder Inc. and reported receiving royalties from multiple publishers, including Routledge, the publisher of the CBT manual used in this study. Dr. Simon reported receiving grant support from the American Foundation for Suicide Prevention, Forest Laboratories, NIMH, and the Department of Defense; consulting for the Massachusetts General Hospital Psychiatry Academy; and having stock options in Elan, Dandreon, G Zero, and Gatekeeper. Dr. Meuret reported receiving grant support from NIH and serving as a consultant for Palo Alto Health Sciences Inc. Dr. Marques reported consulting for the Massachusetts General Hospital Psychiatry Academy and receiving payment for manuscript preparation for Hazelden Publishing and Harvard Health Publications. Dr. Hofmann reported serving as a consultant for Merck-Schering/Plough, receiving grant support from NIMH, and receiving royalties from multiple publishers, including Routledge, the publisher of the CBT manual used in this study. Dr. Pollack noted the following disclosures for the preceding 36 months: Advisory Boards and Consultation: Corcept, Eli Lilly, Johnson and Johnson, Ironwood Pharmaceuticals, Medavante, Merck, Otsuka, Targia Phamaceuticals, and Transcept Research; Grants and Grants Pending: NIDA, NIMH, NCCAM, Bristol Myers Squibb, Euthymics, Forest Laboratories, GlaxoSmithKline, and Eli Lilly; Equity: Doyen Medical, Medavante, Mensante Corporation, Mindsite, Targia Pharmaceuticals; Royalty/patent: SIGH-A, SAFER interviews.
Contract grant sponsor: NIH; contract grant numbers: R01MH078308 (Hofmann) and R01MH075889 (Pollack).
- Issue online: 4 NOV 2013
- Version of Record online: 26 AUG 2013
- Manuscript Accepted: 26 JUL 2013
- Manuscript Revised: 12 JUL 2013
- Manuscript Received: 20 MAY 2013
- NIH. Grant Numbers: R01MH078308, R01MH075889
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.